Bioseeker, May 2007
"AnalyticalTool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged
Global Industry Analysts, Inc., Feb 2006, Pages: 248
Cancer Therapeutics, and Refractory Ovarian Cancer Therapeutics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided
Bioseeker, March 2006, Pages: 101
. According to market analytical studies, the NSCLC drug market is predicted to exceed $4 billion between 2010 and 2015. Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go